Combined passive-active immunization against the hepatitis B virus of 132 newborns of chronic carrier mothers:Long term results

Pediatric Infectious Disease Journal

Volumn 7, Issue 11, 1988, Pages 769-776

  Delage, Gilles ^a   Rémy Prince, Suzanne ^a   Ducic, Slobodan ^a   Pierri, Evelinda ^a   Montplaisir, Serge ^a   Auger, Pierre ^b   Delorme, Laurent ^c   Domaradzki, Maria ^d   Vincelette, Jean ^e   Albert, Guy ^f   Saint Antoine, Pierre ^g   Robert, Andre ^h  

^a UNIVERSITY OF MONTREAL   (Canada)

^b Hôpital Fleury   (Canada)

^c HÔPITAL CHARLES LEMOYNE   (Canada)

^d Hôpital Saint Michel ^*  (Belgium)

^e Hôpital St Luc   (Belgium)

^f Hôpital Sacre Coeur ^*  (France)

^g NOTRE DAME HOSPITAL   (Canada)

^h MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIBODY; HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ANTIBODY RESPONSE; ETHNIC OR RACIAL ASPECTS; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; SEX DIFFERENCE;

CARRIER STATE; CHRONIC DISEASE; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HUMAN; IMMUNIZATION; IMMUNIZATION, PASSIVE; INFANT, NEWBORN; MALE; MOTHERS; SUPPORT, NON-U.S. GOV'T; VIRAL HEPATITIS VACCINES;

EID: 0023808231     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/00006454-198811000-00005     Document Type: Article

References (44)

1. Lee AKY, Ip HMH, Wong VCW. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978; 138:668-71.
2. Shiraki K, Yoshihara N, Sakurai M, Eto T, Kanawa T. Hepatitis B surface antigen and chronic hepatitis in infants born to asymptomatic carrier mothers. Am J Dis Child 1977;131:644-7.
3. Zanetti AR, Magliano EM, Tanyi E, et al. HBIG immunopro-phylaxis of babies born to HBsAg carrier mothers. Dev Biol Stand 1983;54:383-9.
4. Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol 1979;3:237-41.
5. Tong MJ, Thursby MW, Lin JH, Weissman JY, McPeak CM. Studies on the maternal-infant transmission of the hepatitis B virus and HBV infection within families. Prog Med Virol 1981;27:137-47.
6. Chung WK, Yoo JY, Sun SS, et al. Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea. J Infect Dis 1985;151:280-6.
7. Kanai K, Takehiro A, Noto H, et al. Prevention of perinatal transmission of hepatitis B virus to children of e antigen-positive HBV carrier mothers by hepatitis B immune globulin and HBV vaccine. J Infect Dis 1985;151:287-90.
8. Okada K, Kamiyama I, Inomata M, Imai M, Miyakawa Y, Mayumi M. e antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants. N Engl J Med 1976;294:746-9.
9. Committee on Infectious Diseases, American Academy of Pediatrics. Prevention of hepatitis B virus infections. Pediatrics 1985;75:362-4.
10. Beasley RP. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma: epidemiologic considerations. Hepatology 1982;2:2l5-6.
11. Sinatra FR, Shah P, Weissman JY, Thomas DW, Merritt DJ, Tong MJ. Perinatal transmitted acute icteric hepatitis in infants born to hepatitis B surface antigen-positive and antihepatitis B e-positive carrier mothers. Pediatrics 1982;70:557-9.
12. Delaplane D, Yogev R, Crussi F, Shulman S. Fatal hepatitis B in early infancy: the importance of identifying HBsAg-positive pregnant women and providing immunoprophylaxis to their newborns. Pediatrics 1983;72:176-80.
13. Coursaget P, Yvonnet B, Chotard J, et al. Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal). J Med Virol 1987;22:1-5.
14. Reesink HW. Reerink-Brongers EE, Lafeber-Schut BJT, Kal-shoven-Benschop J, Brummelhuis HGJ. Prevention of chronic HBsAg carrier state in infants of HBsAg-positive mothers by hepatitis B immunoglobulins. Lancet 1979;2:436-8.
15. Beasley RP, Hwang LY, Stevens CE, et al. Efficacy of hepatitis B immune globulin (HBIG) for prevention of perinatal transmission of the HBV carrier state: final report of a randomized, double-blind placebo-controlled trial. Hepatology 1983;3:135-41.
16. Maupas P, Chiron JP, Barin F, et al. Efficacy of hepatitis B vaccine in prevention of early HBsAg carrier state in children: controlled trial in an endemic area (Senegal). Lancet 1981;1:289-92.
17. Tada H, Yanagida M, Mishina J, et al. Combined passive and active immunization for preventing perinatal transmission of hepatitis B virus carrier state. Pediatrics 1982;70:613-9.
18. Beasley RP, Lee GCY, Roan CH, et al. Prevention of perinatally transmitted hepatitis B virus infection with hepatitis B immune globulin and hepatitis B vaccine. Lancet 1983;2:1099-1102.
19. Wong VCW, Reesink HW, Reerink-Brongers EE, et al. Prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg by administration of hepatitis B vaccine and hepatitis B immunoglobulin. Lancet 1984;1:921-6.
20. Stevens CE, Toy PT, Tong MJ, et al. Perinatal hepatitis B virus transmission in the United States: prevention by passive-active immunization. JAMA 1985;253:1740-5.
21. Mazel JA, Schalm SW, de Gast BC, et al. Passive-active immunization of neonates of HBsAg positive carrier mothers: preliminary observations. Br Med J 1984;288:513-5.
22. Goudeau A, Lo KJ, Coursaget P, et al. Prevention of hepatitis B virus infection in children born to HBsAg-positive/HBeAg-positive mothers: preliminary results of active and passive-active immunization. Dev Biol Stand 1983;54:399-404.
23. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987;257:2612-6.
24. Shikata T, Michitami Y, Shiraki K, Oda T. Efficacy trial of HBIG and hepatitis B vaccine for the prevention of perinatal HBV transmission. In: Vyas GN, Dienstag JL, Hoofnagel JH, eds. Viral hepatitis and liver disease. Orlando, FL: Grune and Stratton, 1984:593-7.
25. Immunization Practices Advisory Committee. Recommendations for protection against viral hepatitis. MMWR 1985;34:313-24.
26. National Advisory Committee on Immunization. Statement on immunizing agents for the prevention of viral hepatitis. Can Weekly Dis Rep 1987;13:99-106.
27. Immunization Practices Advisory Committee. Immune globulins for protection against viral hepatitis. MMWR 1981;30:423-35.
28. Immunization Practices Advisory Committee. Postexposure prophylaxis of hepatitis B. MMWR 1984;33:285-90.
29. Delage G, Montplasir S, Rémy-Prince S, et al. Prevalence of hepatitis B virus infections in pregnant women in the Montreal area. Can Med Assoc J 1986;134:897-901.
30. Hollinger FB, Adam E, Heiberg D, Melnick JL. Response to hepatitis B vaccine in a young adult population. In: Szmuness W, Alter HJ, Maynard JE, eds. Viral hepatitis, 1981 international symposium. Philadelphia: Franklin Institute Press, 1982:451-66.
31. Henry RJ, Chiamori N, Golub OJ, Berkman S. Revised spec-trophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transminase, and lactic deshydrogenase. Am J Clin Pathol 1960;34:381-98.
32. Feinstein A: Implementation of the outline: outcome events. In: Clinical epidemiology: the architecture of clinical research. Philadelphia: WB Saunders, 1985:311-51.
33. Derso A, Boxall EH, Tarlow MJ, Flewett TH. Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J 1978;1:949-52.
34. Gilbert GL. Prevention of vertical transmission of hepatitis B: the place of routine screening in antenatal care, and the case for immunization of infants at risk. Med J Aust 1984;141:213-6.
35. Uhr JW, Moller G. Regulatory effects of antibody on the immune response. Adv Immunol 1968;8:81-127.
36. Rigelman WE, Mills EL, Quie PG. Immunology of the newborn. In: Feigin RD, Cherry JD, eds. Textbook of pediatric infectious diseases. 2 ed. Philadelphia: WB Saunders, 1987;921-39.
37. Celis E, Abraham KG, Milles RW. Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology 1987;7:563-8.
38. Lee GCY, Hwang LY, Beasley RP, Chen SH, Lee TY. Immu-nogenicity of hepatitis B virus vaccine in healthy Chinese neonates. J Infect Dis 1983;148:526-9.
39. Prozesky OW, Stevens CE, Szmuness W, et al. Immune response to hepatitis B vaccine in newborns. J Infect 1983;7(suppl 1):53-5.
40. Barin F, Goudeau A, Denis F, et al. Immune response in neonates to hepatitis B vaccine. Lancet 1982;1:251-3.
41. Stevens CE, Taylor PE, Tong MJ, et al. Hepatitis B vaccine: an overview. In: Vyas GN, Dienstag JL, Hoofnagel JH, eds. Viral hepatitis and liver disease. Orlando, FL: Grane and Stratton, 1984:275-91.
42. Hadler SC, Francis DP, Maynard JE, et al. Long-term immu-nogenicity and efficacy of hepatitis B vaccine in homosexual men. N Engl J Med 1986;315:209-14.
43. Benhamou E, Courouce AM, Laplanche A, Jungers P, Tron JF, Crosnier J. Long-term results of hepatitis B vaccination in patients on dialysis. N Engl J Med 1986;314:1710-1.
44. Coursaget P, Chotard J, Vincelot P, et al. Seven-year study of hepatitis B vaccine efficacy in infants from an endemic area (Senegal). Lancet 1986;2:1143-5.